MRI versus 64-row MDCT for diagnosis of hepatocellular carcinoma

doi:10.3748/wjg.15.6044

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 48

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4420)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-6) series, Tables (1-3) series.

Item

Count

PDF

414

HTML

3359

Figures (1-6)

368

Tables (1-3)

279

Sum=4420

Dec 28, 2009 (publication date) through Feb 18, 2025

Times Cited of This Article

Times Cited (22)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Dec 28, 2009; 15(48): 6044-6051
Published online Dec 28, 2009. doi: 10.3748/wjg.15.6044

Full Size Figure Download Figure

Figure 1 71-year-old man with biopsy-proven hepatocellular carcinoma (HCC). Detection of an additional tumor nodule by magnetic resonance imaging (MRI), size 12 mm (size category ≤ 15 mm). Multidetector computed tomography (MDCT) demonstrates two hypervascularized tumor nodules in the contrast-enhanced arterial phase (A, arrow) but not in the portal venous phase (B, arrow). MRI arterial phase depicts one more tumor nodule (arrows) in the T2w (C) and the T1w contrast-enhanced early arterial phase (D).

Citation: Pitton MB, Kloeckner R, Herber S, Otto G, Kreitner KF, Dueber C. MRI versus 64-row MDCT for diagnosis of hepatocellular carcinoma. World J Gastroenterol 2009; 15(48): 6044-6051
URL: https://www.wjgnet.com/1007-9327/full/v15/i48/6044.htm
DOI: https://dx.doi.org/10.3748/wjg.15.6044